Luke J Engelking MD PhD, AGAF (He/Him)

Summary

• Dr. Engelking a physician-scientist gastroenterologist, genetic cancer specialist, investigator, and educator. He serves as the Co-Medical Director of UT Southwestern's Cancer Genetics program and its Genetic Cancer Prevention Clinic, where he is accepting new patient referrals (ph: 214-645-2563; f: 214-645-2562).
  
  
  He leads clinic, endoscopy, and research programs focused on hereditary syndromes of GI cancer risk and polyposis, such as Lynch syndrome and Familial Adenomatous Polyposis syndrome. The overarching goal of these programs is cancer prevention care for patients and their families with inherited forms of GI cancers, particularly colorectal cancer. He has completed intensive training from City of Hope and is a certified genetic cancer risk assessment specialist.
  
  
  He completed joint MD/PhD training (2000-2007) at UT Southwestern in Dallas, where he studied cholesterol metabolism under Nobel Laureates Goldstein and Brown. He next completed internal medicine training at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School, and then returned to UT Southwestern for a clinical and research fellowship in gastroenterology (2010-2014). He is now an Associate Professor of Internal Medicine and the Harold C. Simmons Comprehensive Cancer Center. He served as interim Associate Dean of Medical Student Research and Scholarly Activity. His basic science laboratory studied various aspects of lipid metabolism in digestive organs and GI tract neoplasms, supported by research grants from NIH and CPRIT. He has authored numerous high impact research manuscripts published in Journal of Clinical Investigation, Cell Metabolism, and elsewhere.